Antiviral treatment for infants with hepatitis B
Treatments studied
Part of Infections clinical trials.
This trial tests antiviral therapy in babies under 1 year old who have hepatitis B virus (HBV) but no other liver infections. The goal is to see if treatment can help control the virus and protect their liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 1 year old or younger.
- Your child must have a positive test for hepatitis B surface antigen (HBsAg) and hepatitis B virus DNA (HBV DNA).
- Your child's liver enzyme (ALT) level must be no more than 5 times the upper limit of normal, and they should not have serious jaundice.
- You (or your child's legal guardians) must agree to join the study and sign a consent form.
- Your child cannot have other viral infections (like hepatitis A, C, D, E, or HIV) or other liver diseases.
- Your child's white blood cell count must be at least 9 billion per liter, and platelet count at least 90 billion per liter.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well antiviral medicines work for children with long-term hepatitis B. It may help doctors find the best way to treat or stop treatment for kids who have had the virus for a while.
This trial tests if peginterferon alfa-2b can help children with chronic hepatitis B achieve a functional cure. If your child has had hepatitis B for a while and still has the virus in their blood, this study might be an option.
This study tests a new combination of antiviral medicine and an immune-boosting therapy for adults with chronic hepatitis B. It is designed for people who are in the active phase of the infection and have not been treated before.
This trial tests whether adding a short course of interferon to standard antiviral medicine (entecavir) helps younger children with chronic hepatitis B whose immune system has not yet started fighting the virus. It aims to see if this combination can lead to a functional cure.
This trial compares two treatments for young children (ages 3–6) with active chronic hepatitis B: entecavir alone versus entecavir plus a short course of pegylated interferon. The goal is to see if adding interferon helps control the infection better.
This study compares two ways of treating hepatitis B in pregnant women to prevent passing the virus to their babies. It tests whether a standard universal treatment approach works better than a quick, point-of-care test-based strategy.
Hear when a new HBV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.